Supplementation with Folic Acid or 5-Methyltetrahydrofolate and Prevention of Neural Tube Defects: An Evidence-Based Narrative Review
Nutrients · 2024
DOI: 10.3390/nu16183154 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, 2024. Verfasst von María de Lourdes Samaniego-Vaesken und 6 weiteren Autor:innen. Beteiligte Einrichtung: Grupo USP-CEU de Excelencia "Nutrición para la vida (Nutrition for Life)", Ref: E02/0720, Departamento de Ciencias Farmacéuticas y de la Salud, Facul…. Hauptthemen laut MEDLINE: Folic Acid, Neural Tube Defects, Tetrahydrofolates, Dietary Supplements. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ITF RESEARCH PHARMA, S.L.U, ITF RESEARCH PHARMA.
Abstract (Originalsprache)
Background
Folic acid (FA), which in its chemical form is pteroylglutamic acid, is the fully oxidised, water-soluble, monoglutamic form of vitamin B9. This compound is part of the folate group but with higher bioavailability, and it is found in vitamin supplements and fortified foods and drugs. Folate metabolism is complex and associated with various metabolic pathways, all of which confer protection on the cell and allow its survival.
Methods
We conducted a non-systematic search of articles published in English and Spanish including controlled trials, cohort studies, systematic re-views, and meta-analyses were included, as well as key studies in animal models related to pharmacokinetic studies. Search terms encompassed: “folic acid”, “folates”, “5-metyltetrahydrofolate”, “5-MTHF”, “neural tube defects”, “supplementation”, “fortification”, AND “homocysteine” Results: A crucial role demonstrated for FA is to help prevent neural tube defects (NTDs). However, more studies are definitely still needed to establish 5-MTHF as a safe and effective therapeutic approach comparable with FA. Moreover, there is a lack of clinical studies that evaluate the efficacy of 5-MTHF supplementation in the prevention of NTDs. The present evidence-based narrative review discusses differences between FA and 5-MTHF in terms of structure, metabolism, bioavailability, clinical efficacy, and safety.
Conclusions
Despite the potential value of 5-MTHF as an alternative to FA, clinical studies would be urgently needed to support the efficacy, dosage, timing, and/or safety of its use as a supplement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Grupo USP-CEU de Excelencia "Nutrición para la vida (Nutrition for Life)", Ref: E02/0720, Departamento de Ciencias Farmacéuticas y de la Salud, Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Urbaniza…
- Instituto Universitario CEU Alimentación y Sociedad, Facultad de Farmacia, Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, 28660 Boadilla del Monte, Spain.
ORCID-Profile: María de Lourdes Samaniego-Vaesken, Carmen Morais-Moreno, Alejandra Carretero-Krug, Ana María Puga, Ana María Montero-Bravo, Teresa Partearroyo, Varela-Moreiras Gregorio
Förderung
- ITF RESEARCH PHARMA, S.L.U
- ITF RESEARCH PHARMA
Zitieren
APA
Samaniego-Vaesken, M. L., Morais-Moreno, C., Carretero-Krug, A., Puga, A. M., Montero-Bravo, A. M., Partearroyo, T., & Gregorio, V. M. (2024). Supplementation with Folic Acid or 5-Methyltetrahydrofolate and Prevention of Neural Tube Defects: An Evidence-Based Narrative Review. Nutrients. https://doi.org/10.3390/nu16183154
Vancouver
Samaniego-Vaesken ML, Morais-Moreno C, Carretero-Krug A, Puga AM, Montero-Bravo AM, Partearroyo T, et al. Supplementation with Folic Acid or 5-Methyltetrahydrofolate and Prevention of Neural Tube Defects: An Evidence-Based Narrative Review. Nutrients. 2024. doi:10.3390/nu16183154
BibTeX
@article{SamaniegoVaesken2024,
author = {Samaniego-Vaesken, María de Lourdes and Morais-Moreno, Carmen and Carretero-Krug, Alejandra and Puga, Ana María and Montero-Bravo, Ana María and Partearroyo, Teresa and Gregorio, Varela-Moreiras},
title = {Supplementation with Folic Acid or 5-Methyltetrahydrofolate and Prevention of Neural Tube Defects: An Evidence-Based Narrative Review},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16183154}
}
EUVIMED